Report cover image

Esteve Pharmaceuticals, S.A. - Strategic SWOT Spotlight

Publisher Quaintel Research
Published Aug 27, 2024
Length 47 Pages
SKU # QTELR19119622

Description

Esteve Pharmaceuticals, S.A. - Strategic SWOT Spotlight


Esteve Pharmaceuticals, S.A. - Strategic SWOT Spotlight is a comprehensive and easily accessible overview of The Esteve Pharmaceuticals, S.A.'s business operations. It provides a Snapshot of the company's position in the industry compared to competitors. The report includs key executives, products and services, ESG spotlight, Corporate Strategy, Business Description, Helicopter view of SWOT Analysis, Competitive Landscape and latest events.

Key Highlights

Esteve Pharmaceuticals, S.A. is a global pharmaceutical company that operates in the research, development, and commercialization of innovative medicines and treatments. The company offers a wide range of products and services, including prescription drugs, over-the-counter medications, and medical devices. Esteve Pharmaceuticals focuses on therapeutic areas such as pain management, neurology, and respiratory diseases. They also provide services in drug discovery and development, clinical trials, and manufacturing. Additionally, the company offers patient support programs and educational resources to improve patient outcomes and quality of life. Esteve Pharmaceuticals is committed to providing high-quality, safe, and effective treatments to patients worldwide. Founded in 1929, the company is headquartered in Barcelona, Catalonia, Spain.

Esteve Pharmaceuticals, S.A. in the News:-
  • 16-May-2024 - ESTEVE CONSOLIDATES ITS DOUBLE-DIGIT GROWTH AND REACHES €710 MILLION IN NET INCOME
  • 25-Apr-2024 - ESTEVE SIGNS A BINDING OFFER TO ACQUIRE HRA PHARMA RARE DISEASES, A PERRIGO COMPANY AFFILIATE
  • 08-Apr-2024 - JACOB TOLSTRUP, JOINS ESTEVE AS CHIEF BUSINESS DEVELOPMENT OFFICER
  • 29-Feb-2024 - ESTEVE RENEWS ITS BOARD OF DIRECTORS TO CONTINUE DRIVING STRATEGIC GROWTH
  • 07-Mar-2023 - ESTEVE BRINGS TO MARKET THE FIRST INHALED RESCUE TREATMENT DESIGNED TO CONTROL OFF EPISODES IN PARKINSON'S DISEASE
Scope

Company Fundamentals:- These fundamentals offer valuable insights into Esteve Pharmaceuticals, S.A.'s operations, geographical presence, products and services, ESG spotlight, Corporate Strategy, Business Description and SWOT spotlight, aiding in a comprehensive understanding of the organization.

Reasons to Buy
  • Helicopter view of company's internal and external factors through SWOT analysis - Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers. - Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations. - Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Table of Contents

47 Pages
Table of Contents
Tables
Charts
Esteve Pharmaceuticals, S.A. - Key Company Facts
Esteve Pharmaceuticals, S.A. - Company Description
Esteve Pharmaceuticals, S.A. - Top Executives
Esteve Pharmaceuticals, S.A. - Head Office & Locations
Head Office - Country
Esteve Pharmaceuticals, S.A. - Products and Services
Products
Services
Esteve Pharmaceuticals, S.A. - Corporate Strategy
Esteve Pharmaceuticals, S.A. - Business Description
Dermatology
Psychiatry and Central Nervous System (CNS)
Esteve Pharmaceuticals, S.A. - ESG Spotlight
Environment
Social
Corporate Governance
Esteve Pharmaceuticals, S.A. - SWOT Spotlight
Overview
Strengths
Weaknesses
Opportunities
Threats
Competing Players
Snapshot of Competing Players
Almirall SA
Key Company Facts
Company Description
Key Financials:
Grifols SA
Key Company Facts
Company Description
Key Financials:
Chiesi Farmaceutici S.p.A.
Key Company Facts
Company Description
Alfasigma S.p.A
Key Company Facts
Company Description
Covex SA
Key Company Facts
Company Description
Esteve Pharmaceuticals, S.A. - In the News
16-May-2024- ESTEVE CONSOLIDATES ITS DOUBLE-DIGIT GROWTH AND REACHES €710 MILLION IN NET INCOME
25-Apr-2024- ESTEVE SIGNS A BINDING OFFER TO ACQUIRE HRA PHARMA RARE DISEASES, A PERRIGO COMPANY AFFILIATE
08-Apr-2024- JACOB TOLSTRUP, JOINS ESTEVE AS CHIEF BUSINESS DEVELOPMENT OFFICER
29-Feb-2024- ESTEVE RENEWS ITS BOARD OF DIRECTORS TO CONTINUE DRIVING STRATEGIC GROWTH
07-Mar-2023- ESTEVE BRINGS TO MARKET THE FIRST INHALED RESCUE TREATMENT DESIGNED TO CONTROL OFF EPISODES IN PARKINSON'S DISEASE
Appendix
Definitions
SWOT Analysis
PESTLE Analysis
Value Chain Analysis
ESG Spotlight
Research Methodology
Disclaimer
Contact Us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us